ISSN: 1300-0012 | E-ISSN: 2458-9446
Volume : 37 Issue : 1 Year : 2025
Quick Search

CLOCKSS system has permission to ingest, preserve, and serve this Archival Unit

Adipose derived stromal vascular fraction cells therapy in hemophilic arthropathy: A case report [Ağrı]
Ağrı. 2025; 37(1): 62-65 | DOI: 10.14744/agri.2022.37043

Adipose derived stromal vascular fraction cells therapy in hemophilic arthropathy: A case report

Derya Güner1, Can Eyigör2
1Department of Algology, Health Sciences University, İzmir Tepecik Training and Research Hospital, İzmir, Türkiye
2Department of Anesthesiology and Reanimation, Ege University Faculty of Medicine, İzmir, Türkiye

Stromal vascular fraction (SVF) is a heterogeneous collection of cells obtained from adipose tissue through lipoaspiration and is an alter-native intraarticular treatment option, especially in osteoarthritis (OA). The anti-inflammatory and extracellular tissue repair-stimulating properties of SVF increase its effectiveness in regeneration and repair mechanisms. One of the most common symptoms of hemophilia A and B is hemophilic arthropathy (HA). If HA is not adequately managed initially, patients may require major surgery, including total joint arthroplasty. In a 34-year-old male patient who was treated with intraarticular adipose-derived SVF with the diagnosis of hemophilia B and right grade 4 hemophilic knee arthrosis, clinical and radiological scores showed significant improvement in the 3rd month, 6th month, and 1st year controls after the procedure. Intraarticular adipose-derived SVF treatment should be kept in mind as an effective treatment option with minimal invasiveness and few side effects in HA that does not respond to conservative treatments.

Keywords: Hemophilic arthrosis, intraarticular injection, mesenchymal stem cells, stromal vascular fraction.

Corresponding Author: Derya Güner, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE